Search

PROCEPT BioRobotics Corp

Fechado

SetorSaúde

20.65 0.34

Visão Geral

Variação de preço das ações

24h

Atual

Mín

20.59

Máximo

20.84

Indicadores-chave

By Trading Economics

Rendimento

-27M

-58M

Vendas

11M

94M

EPS

-0.47

Margem de lucro

-61.905

Funcionários

888

EBITDA

5.1M

-24M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.04% upside

Dividendos

By Acuity

Próximos Ganhos

3 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

171M

1.2B

Abertura anterior

20.31

Fecho anterior

20.65

Sentimento de Notícias

By Acuity

50%

50%

126 / 340 Ranking em Healthcare

PROCEPT BioRobotics Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

28 de ago. de 2026, 19:46 UTC

Procept Biorobotics Corp shares are higher since Thursday's close, despite earlier declines during the session. No specific news was identified for today's movement.

26 de ago. de 2026, 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit alleging securities fraud related to inflated handpiece sales, contributing to a decline in shares during Wednesday's session.

25 de ago. de 2026, 19:46 UTC

Procept Biorobotics shares are higher today amid favorable market conditions, including lower crude oil prices and decreasing Treasury yields. No specific company news was identified.

24 de ago. de 2026, 19:36 UTC

News

Procept Biorobotics faces multiple class action lawsuits alleging securities fraud, contributing to negative sentiment as shares trade lower today.

21 de ago. de 2026, 23:26 UTC

Procept Biorobotics shares are higher in after-market trading, amid a broader market recovery following recent geopolitical tensions and their impact on energy prices.

20 de ago. de 2026, 20:06 UTC

News

Shares of Procept Biorobotics Corp are lower following a class action lawsuit alleging false sales and revenue statements, impacting investor sentiment amid negative earnings reports.

19 de ago. de 2026, 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit from Kaplan Fox & Kilsheimer LLP but shares are trading higher during Wednesday's session.

18 de ago. de 2026, 19:16 UTC

Procept Biorobotics Corp shares are higher, trading near the upper end of their one-month range, despite pulling back from earlier session highs.

17 de ago. de 2026, 19:56 UTC

News

Procept Biorobotics faces downward pressure amid class action lawsuits alleging securities fraud, contributing to negative sentiment and a decline since Friday's close.

14 de ago. de 2026, 19:46 UTC

News

Procept Biorobotics faces class action lawsuits alleging securities fraud, leading shares to decline during Friday's session after earlier reaching a high.

13 de ago. de 2026, 20:06 UTC

Procept Biorobotics Corp is gaining during Thursday's session, following strong momentum and peaking at 7.26% earlier, despite a pullback in recent trading.

12 de ago. de 2026, 20:01 UTC

News

Procept Biorobotics shares are lower amid a class action lawsuit alleging securities fraud related to undisclosed inventory issues and misleading sales practices.

11 de ago. de 2026, 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

10 de ago. de 2026, 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

7 de ago. de 2026, 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6 de ago. de 2026, 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5 de ago. de 2026, 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4 de ago. de 2026, 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3 de ago. de 2026, 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31 de jul. de 2026, 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

30 de jul. de 2026, 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

29 de jul. de 2026, 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

28 de jul. de 2026, 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

27 de jul. de 2026, 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

22 de jul. de 2026, 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

21 de jul. de 2026, 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

20 de jul. de 2026, 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Comparação entre Pares

Variação de preço

PROCEPT BioRobotics Corp Previsão

Preço-alvo

By TipRanks

11.04% parte superior

Previsão para 12 meses

Média 23.13 USD  11.04%

Máximo 29 USD

Mínimo 19 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para PROCEPT BioRobotics Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

11 ratings

3

Comprar

7

Manter

1

Vender

Sentimento

By Acuity

126 / 340 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat